Outset Medical
94 hedge funds and large institutions have $352M invested in Outset Medical in 2025 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 8 closing their positions.
413% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 8
116% more capital invested
Capital invested by funds: $163M → $352M (+$189M)
110% more call options, than puts
Call options by funds: $915K | Put options by funds: $436K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
54% more funds holding
Funds holding: 61 → 94 (+33)
22.32% more ownership
Funds ownership: 83.23% → 105.55% (+22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$6.62M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.87M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$4.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.72M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$3.18M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.01M |
| 4 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$1.3M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.01M |
OM Hedge Fund Activity: Q2 2025 in Review
94 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2025, worth a combined $352M — up 116% from $163M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new OM positions and 8 closed out — a net gain of 33 holders — while 25 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $14.3M. The largest seller was Alyeska Investment Group, cutting an estimated $3.72M.
- 94 institutional investors held Outset Medical (OM) as of Q2 2025, up from 61 in Q1 2025.
- Funds reported $352M of Outset Medical stock for Q2 2025, up 116% quarter-over-quarter.
- 41 funds opened new Outset Medical positions in Q2 2025 and 8 closed out, a net change of +33 holders.
- The largest Outset Medical buyer in Q2 2025 was BlackRock, an estimated $14.3M added.
- The largest Outset Medical seller in Q2 2025 was Alyeska Investment Group, an estimated $3.72M sold.
Based on aggregated 13F filings for Q2 2025.